Cognition Therapeutics

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Fri, March 17, 2023

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Fri, October 6, 2023

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Wed, November 8, 2023

Filed a patent for "compositions for treating neurodegenerative diseases" on Thu, December 12, 2024

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Fri, February 2, 2024

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Thu, May 9, 2024

Filed a patent for "compositions for treating dry age-related macular degeneration (amd)" on Thu, January 11, 2024

Filed a patent for "compositions and methods for treating neurologic diseases" on Thu, May 23, 2024

Filed a patent for "isoindoline compositions and methods for treating neurodegenerative disease" on Mon, July 18, 2022

Filed a patent for "method of decreasing amyloid beta monomer levels in patients with cognitive decline" on Thu, March 30, 2023